Company profile
Fuse Diagnostics Limited
Fuse
Fuse Diagnostics Limited is a UK company with status active founded in 2022 based in East of England.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Memorandum Articles
IncorporationMA | Transaction MzUyNzgxMTk4MGFkaXF6a2N4 | Paper/PDF filed
Published 03 Jul 2026 23:07
Resolution
ResolutionRESOLUTIONS | Transaction WUY0U0I1TlZhZGlxemtjeA | Paper/PDF filed
Published 03 Jul 2026 23:07
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQ0NDcxOTk2NWFkaXF6a2N4
Published 24 Nov 2024 10:04
Accounts With Accounts Type Micro Entity
Accounts AnalysedAA | Transaction MzQzMzM5MTk4NWFkaXF6a2N4
Published 26 Aug 2024 21:05
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of an Instrument-Free Molecular Diagnostic Test for Chlamydia and Gonorrhoea
1 Jun 2024 to 30 Nov 2025
Chlamydia (CT) and Gonorrhoea (NG) are the two most prevalent sexually transmitted infections, with 129m and 82m cases worldwide in 2020, respectively. Most CT/NG infections are asymptomatic yet if left untreated can cause pelvic inflammatory disease, leading to infertility and ectopic pregnancy. The infection rate in developed countries has increased per...
Preparing for the Next Pandemic - a Rapid, Low-Cost, Instrument-Free Molecular Diagnostic Test for Respiratory Pathogens
1 Nov 2023 to 30 Apr 2025
In this project we are developing a next-generation instrument-free molecular diagnostic test for seasonal respiratory viruses (Flu, COVID-19 and RSV) with potential to transform management of the next pandemic. The COVID-19 pandemic highlighted the fundamental flaws with conventional diagnostic tests for respiratory viruses. Whilst laboratory PCR (molecu...
Engineering Enzymes to Transform Molecular Diagnostics
1 Jun 2023 to 31 Oct 2023
This project is focussed on engineering enzymes to realise a highly innovative instrument-free molecular diagnostic testing platform. The COVID-19 pandemic highlighted the flaws with conventional approaches to the detection of respiratory viruses. Whilst laboratory PCR (molecular) tests exhibit gold-standard performance they require specialist equipment a...